Ausgabe 2/2021
Inhalt (28 Artikel)
Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer
Mian Liu, Pei Chen, Hui-Yu Hu, Deng-jie Ou-yang, Rooh-afza Khushbu, Hai-long Tan, Peng Huang, Shi Chang
The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos
How to transfer traditional knowledge about medicinal herbs? or TCM plants: a black box for modern oncologists
Judith Büntzel, Oliver Micke, Jens Büntzel
Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis
Marineta Kovacheva, Michael Zepp, Stefan Berger, Martin R. Berger
The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
Richard Drexler, Mirco Küchler, Kim C. Wagner, Tim Reese, Bernd Feyerabend, Moritz Kleine, Karl J. Oldhafer
Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma
Bin Pan, Xiangbo Bu, Menghan Cao, Xin Zhang, Tianqun Huo, Ziang Li, Xiao Gao, Li Jing, Xuanxiang Luo, Hu Feng, Feng Yuan, Kaijin Guo
Experimental and clinical studies on radiation and curcumin in human glioma
Peter Sminia, Jaap van den Berg, Arthur van Kootwijk, Eline Hageman, Ben J. Slotman, Wilko F. A. R. Verbakel
Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer
Juan Yang, ZhouXue Wu, Yao Chen, ChuanFei Hu, Dong Li, Yue Chen, Saber Imani, QingLian Wen, ShaoZhi Fu, JingBo Wu
Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma
Sang Yun Ha, So-Young Yeo, Keun-Woo Lee, Seok-Hyung Kim
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
Gazanfer Belge, Francesca Grobelny, Arlo Radtke, Jacqueline Bodes, Cord Matthies, Christian Wülfing, Klaus-Peter Dieckmann
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways
Kelly L. Hamilton, Stephanie A. Sheehan, Edward P. Retzbach, Clinton A. Timmerman, Garret B. Gianneschi, Patrick J. Tempera, Premalatha Balachandran, Gary S. Goldberg
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis
Roberta Carosio, Vincenzo Fontana, Luca Mastracci, Paola Ferro, Federica Grillo, Barbara Banelli, Pier Aldo Canessa, Paolo Dessanti, Antonella Vigani, Anna Morabito, Ulrich Pfeffer, Alessandro Poggi, Silvio Roncella, Maria Pia Pistillo
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation
Fubo Wang, Wei Zhang, Zijian Song, Maoyu Wang, Hanxiao Wu, Yang Yang, Rui Chen
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing
Junpeng Wang, Xin Li, Xiaoqiang Wu, Zhiwei Wang, Chan Zhang, Guanghui Cao, Kangdong Liu, Tianzhong Yan
Serum factor(s) from lung adenocarcinoma patients regulates the molecular clock expression
Yi Chang, Chunsong Zhao, Hui Ding, Ting Wang, Caixia Yang, Xiuhong Nie, Yanning Cai
Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy
Yanyu Bi, Yiming Jiang, Xia Li, Guoxin Hou, Kesang Li
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers
Giulia Girolimetti, Lorena Marchio, Antonio De Leo, Miriam Mangiarelli, Laura Benedetta Amato, Simone Zanotti, Mario Taffurelli, Donatella Santini, Giuseppe Gasparre, Claudio Ceccarelli
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Zelin Hou, Yu Pan, Qinglin Fei, Yali Lin, Yuanyuan Zhou, Ying Liu, Hongdan Guan, Xunbin Yu, Xianchao Lin, Fengchun Lu, Heguang Huang
Improved outcomes in metastatic germ cell cancer: results from a large cohort study
Marcus Hentrich, Jessica Debole, Vindi Jurinovic, Arthur Gerl
Effects of N-acetylcysteine inhalation therapy on the quality of life of patients with head and neck cancer who are receiving radiation therapy: a prospective non-randomized controlled multi-center study
Ho-Ryun Won, Geon ho Lee, Jin Hwan Kim, Sang Hyuk Lee, Soon Young Kwon, Seung-Kuk Baek, Chang Hwan Ryu, Sang Joon Lee, Il-Seok Park, Sung-Chan Shin, Dong Wook Lee, Phil-Sang Chung, Bon Seok Koo
Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas
Arne Böttcher, Christian S. Betz, Stefan Bartels, Bjoern Schoennagel, Adrian Münscher, Lara Bußmann, Chia-Jung Busch, Steffen Knopke, Eric Bibiza, Nikolaus Möckelmann
Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience
Peng Jin, Xiaoyan Ji, Shuai Ma, Wenzhe Kang, Hao Liu, Yang Li, Fuhai Ma, Haitao Hu, Weikun Li, Yantao Tian
Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost
Tian-Qi Du, Xiang Li, Wei-Si Zhong, Jian-Dong Tian, Yu-Xia Zhao, Dan Liu
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
M. Markus, A. Abendroth, R. Noureddine, A. Paul, S. Breitenbuecher, I. Virchow, K. W. Schmid, P. Markus, B. Schumacher, M. Wiesweg, J. Wendling, B. Mende, J. T. Siveke, M. Schuler, S. Kasper
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
Xiaoting Ma, Shan Wang, Yujian Zhang, Huamin Wei, Jing Yu
Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child–Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria
Xi Xu, Xingyu Pu, Li Jiang, Yang Huang, Lunan Yan, Jiayin Yang, Tianfu Wen, Bo Li, Hong Wu, Wentao Wang
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
Saad Z. Usmani, Maria-Victoria Mateos, Vania Hungria, Shinsuke Iida, Nizar J. Bahlis, Hareth Nahi, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, John Fastenau, Mary Slavcev, Christoph Heuck, Xiang Qin, Huiling Pei, Tara Masterson, Kristen Lantz, Katharine S. Gries
Further discussion on the association between desmoglein 2 and tumor size of non-small cell lung cancer
Siyuan Hao, Jiayi Liu, Jia Ma